Summary
This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants further development. In addition to preclinical efficacy, accompanying pharmacodynamic and pharmacokinetic studies would be supported. Therapeutic agents include small molecules, biologics or biotechnology-derived products. The goal of this NOFO is to spur therapeutic development for a variety of rare diseases by advancing projects to the point where they would attract subsequent investment supporting full Investigational New Drug (IND) application development or progression to clinical trials in the case of repurposing or repositioning.
Eligibility
- City Or Township Governments
- For Profit Organizations Other Than Small Businesses
- Independent School Districts
- Other
- Special District Governments
- Native American Tribal Governments Federally Recognized
- Nonprofits Non Higher Education Without 501c3
- County Governments
- Public and Indian Housing Authorities
- Small Businesses
- Native American Tribal Organizations Other Than Federally Recognized Tribal Governments
- Private Institutions of Higher Education
- State Governments
- Public and State Institutions of Higher Education
- Nonprofits Having A 501(c)(3) Status With the Irs Other Than Institutions of Higher Education
Funding categories
- Health
Official source and attribution
This directory republishes federal opportunity information sourced from Simpler.Grants.gov and Grants.gov. Local Business Ranks is not affiliated with or endorsed by the federal government. Always rely on the official opportunity record for application requirements and changes.
Open the official federal record